Kim Paul

Reported to SECin USFilings at 2 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

4
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Fulgent Genetics, Inc.CFO and TreasurerAdministrative$40,8842,087 sharesSep 3, 2026Fulgent Genetics, Inc.CFO and Treasurer$40,884Admin · Sep 3Administrative2,087Sep 3, 2026
Fulgent Genetics, Inc.CFO and TreasurerAdministrative$23,1381,168 sharesAug 28, 2026Fulgent Genetics, Inc.CFO and Treasurer$23,138Admin · Aug 28Administrative1,168Aug 28, 2026
EXAGEN INC.—Awardnothing paid37,500 sharesAug 19, 2026EXAGEN INC.nothing paidAward · Aug 19Award37,500Aug 19, 2026
Fulgent Genetics, Inc.CFO and TreasurerAdministrative$54,0332,747 sharesJul 28, 2026Fulgent Genetics, Inc.CFO and Treasurer$54,033Admin · Jul 28Administrative2,747Jul 28, 2026